News Everything that happens at IrsiCaixa, at your fingertips. Breadcrumb Home News Latest news HIV Vaccines 03/05/2023 IrsiCaixa designs HIV-like particles that induce an effective immune response in preclinical studies HIV 13/04/2023 New insights on the early stages of HIV infection in the human body SARS-CoV-2 Vaccines 31/03/2023 HIPRA's COVID-19 vaccine, developed with the scientific support of IrsiCaixa, receives a positive opinion from the European Medicines Agency See all Press Contact the communications department and access our press releases. See the press area Outreach We bring science closer to society through different activities. Find out more here Social media You will also find us on social networks. Do you follow us?
HIV Vaccines 03/05/2023 IrsiCaixa designs HIV-like particles that induce an effective immune response in preclinical studies
SARS-CoV-2 Vaccines 31/03/2023 HIPRA's COVID-19 vaccine, developed with the scientific support of IrsiCaixa, receives a positive opinion from the European Medicines Agency